A staff notice sent out on Monday (October 16) from the Toronto Stock Exchange made its plans known to deter Canadian cannabis businesses from continuing business activities in the US, given the uncertainty of the legality of marijuana.
As it looks to increase the restrictions on cannabis stocks already operating or associated directly with interests in the US, Reuters reports, the exchange is consider delisting some of these stocks. The article continued, stating that Ungad Chadda, TMX’s head of capital formation for equity markets, said some of the issuers in the exchange “are not in compliance” with the TSX’s requirements.
One of the largest licensed producers (LPs) of medical cannabis in Canada, Aphria (TSX:APH), has significant interest in the US.  Earlier this year, the company established a heavy partnership with Liberty Health Sciences (CSE:LHS), a US-based company that focuses on acquiring license-ready medical cannabis operations. Its primary  focus is in Florida.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Impact to Aphria and its business

Aphria’s took a direct hit to its stock on Tuesday (October 17), dropping 13.38 percent. The story wasn’t much better on Wednesday as its share price experienced a 1.74 percent decline to close the trading day at $6.74
In a statement issued by Aphria on Tuesday, Vic Neufeld, chief executive officer called the staff notice “extremely broad,” and said it would be difficult to determine the impact it would have on the company’s business.
“[W]e believe the TSX’s recent staff guidance… does not properly apportion the weight and context that must be applied to the current split between U.S. Federal and state laws,” Neufeld said in a statement.
In an interview with Business News Network, Neufeld questioned the rationale of the decision and what the company intends to do next.
“The train has left the station in many, many, many states and eventually the feds will, in our opinion, integrate both properly for medical purposes,” Neufeld said. He added Aphria plans to present its case and hold a dialogue with “the powers to be.”
Neufeld emphasize his company has been straightforward regarding its use of earnings capital to acquire its US options, instead of raising money through a financial institution in Canada and then using that money in the states. Neufeld said the TSX announcement completely blindsided his company.


Second largest exchange responds

As a counter to the larger exchange, the Canadian Securities Exchange also issued a notice welcoming cannabis businesses with US activity. Richard Carleton, chief executive officer of the CSE told the Investing News Network (INN) the exchange wanted disclosure and transparency from cannabis companies with US aspirations as to the risk involved in their plans.
Louis Morisset, chair of the Canadian Securities Administrators (CSA) said in a statement, they expect issuers with US activity to address all the legal and regulatory environments they face in their disclosures.
“[I]ncluding any risks that result from changes in the approach to enforcement of US federal law,” Morisset added.

State of the US cannabis market

Several states have legalized the use of medical cannabis and have even allowed the sale of the recreational product. However, on a federal level, the drug is still illegal and makes any business related to it complicit. Attorney General Jeff Sessions has been vocal on his stance against the drug and any business operation related to it.
Sessions has asked Congress, in writing, for support in stopping down the expansion of the industry.
I believe it would be unwise for Congress to restrict the discretion of the [Justice] Department to fund particular prosecutions,” Sessions wrote. “The [Justice] Department must be in a position to use all laws available to combat the transnational drug organizations and dangerous drug traffickers who threaten American lives.

Different type of response from other LPs

Some companies welcomed the announcement by the TSX. Canopy Growth (TSX:WEED) released a statement “applauding” the decision by the exchange. Canopy has been vocal in its position against operating in the US in any significant way as a violation of the TSX listing obligations.
“[Canopy] commends the decisive action taken today and encourages other regulatory bodies to follow the self-regulatory step taken by the TSX,” the company wrote.
Bruce Linton, chief executive officer for Canopy said the notice was a step in the right direction and called it a good day for the cannabis sector.
“[T]his will ensure our sector can operate with the credibility and professionalism institutional investors expect of companies listed in Canada.”
Don’t forget to follow us @INN_LifeScience and @INN_Cannabis for real-time news updates!
Securities Disclosure: I, Bryan Mc Govern, hold no direct investment interest in any company mentioned in this article.

US Election 2020 and Cannabis

 
Investing in cannabis? Read what experts have to say about cannabis and the US Election!
 

Codebase Ventures Inc. (“Codebase” or the “Company”) (CSE:CODE)(FSE:C5B)(OTCQB:BKLLF) announces it has completed a first closing of a non-brokered private placement of up to $2,000,000. The Company accepted subscriptions for 13,740,000 units at a price of $0.05 per unit, for gross proceeds of $687,000. Each unit consists of one common share and one common share purchase warrant. Each warrant entitles the holder to purchase one additional common share at $0.075 for a period of two years from the date of closing, subject to the option of the Company to accelerate the expiry date in the event that its shares trade at $0.15 or more for 10 consecutive days

The Company paid $18,000 in cash and issued 160,000 warrants on the same terms as noted above to qualified finders. Securities issued pursuant to this tranche are subject to trading restrictions until April 5, 2021. The Company is expecting to complete the financing by December 16, 2020. Proceeds will be used for working capital and to fund future investments.

Keep reading... Show less

Hill Street Beverage Company Inc. (TSXV: BEER) (“Hill Street” or the “Company”), announces that further to its press release dated December 3, 2020, the TSX Venture Exchange has approved the repricing of 19,405,804 warrants of the Company that were originally issued on July 27, 2018, to $0.10. These warrants are set to expire on December 31, 2020.

For anybody wishing to exercise these Warrants, please contact the Chief Executive Officer, Terry Donnelly at the particulars below.

Keep reading... Show less

Wall Street Reporter, the trusted name in financial news since 1843, has published reports on the latest comments and insights from leaders at: Tilray, Inc. (NASDAQ: TLRY), Icanic Brands (OTC: ICNAF) (CSE: ICAN), Aurora Cannabis (NYSE: ACB) (TSX: ACB), and HEXO Corp. (NYSE: HEXO)

Cannabis leaders are focusing on innovation in premium branding, global expansion, and tight operational execution in the drive towards profitability. Wall Street Reporter highlights the latest comments from industry thought leaders:

Keep reading... Show less

TransCanna Holdings Inc. (CSE: TCAN) (FSE: TH8) (“TransCanna” or the “Company”) is pleased to announce that it has closed the 2nd and final tranche of its Unit financing. In connection with the closing, the Company issued 1,356,873 Units at a price of $0.55 per Unit, for gross proceeds of $746,280.15. Each Unit consists of one (1) common share and one (1) warrant. Each warrant entitles the holder to purchase one common share of the Company, at an exercise price of $0.75 per share, for a period of two years from the date of issuance. The warrants are subject to an acceleration right that allows the Company to give notice of an earlier expiry date if the Company’s share price on the CSE (or such other stock exchange the Company’s shares may be trading on) is equal to or greater than $1.25 for a period of 20 consecutive trading days. Finder’s fees of $42,542, 3,200 Finder’s shares and 80,550 Finder’s warrants were issued in connection with finder’s fees payable.

In total, the Company raised gross proceeds of $1,757,180 and issued 3,194,873 Units.

Keep reading... Show less

 Sweet Earth Holdings Corp. (CSE: SE) (FSE: 1KZ1) (OTCQB: SEHCF) (“Sweet Earth” the “Company”) is pleased to announce that it has received full Depository Trust Company (“DTC”) eligibility in the United States. On October 20, 2020, Sweet Earth announced that its shares had been listed on the United States’ Over-The-Counter Bulletin (“OTCQB”) under the ticker SEHCF.

DTC status means that Sweet Earth shares are now eligible to be transferred between brokerage accounts within the United States and significantly augments the ease in which American-based investors are able to trade Sweet Earth shares.

Keep reading... Show less